Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

RECURSION PHARMACEUTICALS, INC.

(RXRX)
  Report
Delayed Quote. Delayed Nasdaq - 11/26 01:00:01 pm
18.91 USD   +0.59%
11/10Health Care Stocks Outlasting Declining Biotechs
MT
11/10Health Care Stocks Slightly Higher Amid Market Malaise Wednesday
MT
11/10Recursion Q3 Loss Narrows as Revenue Improves
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Health Care Stocks Ending Near Top of Thursday Leaderboard

10/07/2021 | 04:01pm EST


© MT Newswires 2021
All news about RECURSION PHARMACEUTICALS, INC.
11/10Health Care Stocks Outlasting Declining Biotechs
MT
11/10Health Care Stocks Slightly Higher Amid Market Malaise Wednesday
MT
11/10Recursion Q3 Loss Narrows as Revenue Improves
MT
11/10RECURSION PHARMACEUTICALS : Q3 Earnings Snapshot
AQ
11/10RECURSION PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Cond..
AQ
11/10Recursion Provides Business Updates and Reports Third Quarter 2021 Financials - Form 8-..
PU
11/10RECURSION PHARMACEUTICALS, INC. : Results of Operations and Financial Condition, Regulatio..
AQ
11/10Recursion Provides Business Updates and Reports Third Quarter 2021 Financials
PR
11/10Earnings Flash (RXRX) RECURSION Posts Q3 Revenue $2.5M
MT
10/13Certain Class B Common Stock of Recursion Pharmaceuticals, Inc. are subject to a Lock-U..
CI
More news
Analyst Recommendations on RECURSION PHARMACEUTICALS, INC.
More recommendations
Financials (USD)
Sales 2021 10,4 M - -
Net income 2021 -169 M - -
Net cash 2021 318 M - -
P/E ratio 2021 -15,4x
Yield 2021 -
Capitalization 3 196 M 3 196 M -
EV / Sales 2021 276x
EV / Sales 2022 274x
Nbr of Employees 330
Free-Float 77,7%
Chart RECURSION PHARMACEUTICALS, INC.
Duration : Period :
Recursion Pharmaceuticals, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends RECURSION PHARMACEUTICALS, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 18,91 $
Average target price 33,20 $
Spread / Average Target 75,6%
EPS Revisions
Managers and Directors
Chistopher C. Gibson Chief Executive Officer & Director
Tina Larson President & Chief Operating Officer
Michael Secora Chief Financial Officer
Ramon Martin Chavez Márquez Independent Chairman
Benjamin Mabey Chief Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
RECURSION PHARMACEUTICALS, INC.0.00%3 196
GILEAD SCIENCES, INC.20.61%88 146
BIONTECH SE326.89%84 049
REGENERON PHARMACEUTICALS33.17%67 266
WUXI APPTEC CO., LTD.24.40%64 416
VERTEX PHARMACEUTICALS-22.32%46 678